Detection of high-risk human papillomavirus by two molecular techniques:: Hybrid capture and linear array

被引:7
作者
de Antonio, Jesus Chacon [1 ]
Fernandez-Olmos, Ana [1 ]
Mercadillo, Maria [1 ]
Lindemann, Maria Luisa Mateos [1 ]
Mochales, Fernando Baquero [1 ]
机构
[1] Hosp Ramon & Cajal, Microbiol Serv, E-28034 Madrid, Spain
关键词
hybrid capture; HR-HPV linear array;
D O I
10.1016/j.jviromet.2008.01.021
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A number of human papillomaviruses (HPV) are the etiological agents of cervical cancer. The present study compared the performance of the hybrid capture method with that of linear array for the detection of high-risk HPV in 218 cervical samples. For the linear array technique, the DNA was extracted using two different procedures, one manual and the other automated. There was no difference in high-risk HPV (HR-HPV) delectability between the two extraction procedures but the automated procedure had the advantages of simplicity, time and efficiency. There was agreement in 199 (91.3%) of the results. The K value for the two assays was 0.81 indicative of "near perfect" agreement. Both methods, hybrid capture and linear array, are sensitive options for detection of HPV in cervical samples. Linear array enables the identification of the genotype present in the sample and the presence of multiple infections. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:163 / 166
页数:4
相关论文
共 12 条
[1]   Carcinogenicity of human papillomaviruses [J].
Cogliano, V ;
Baan, R ;
Straif, K ;
Grosse, Y ;
Secretan, B ;
El Ghissassi, F .
LANCET ONCOLOGY, 2005, 6 (04) :204-204
[2]   A COEFFICIENT OF AGREEMENT FOR NOMINAL SCALES [J].
COHEN, J .
EDUCATIONAL AND PSYCHOLOGICAL MEASUREMENT, 1960, 20 (01) :37-46
[3]  
Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357
[4]  
*INT MON FUND, 1995, MYANM REC EC DEV, P64
[5]   A controlled trial of a human papillomavirus type 16 vaccine [J].
Koutsky, LA ;
Ault, KA ;
Wheeler, CM ;
Brown, DR ;
Barr, E ;
Alvarez, FB ;
Chiacchierini, LM ;
Jansen, KU .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (21) :1645-1651
[6]  
Lorincz A, 2001, PAPILLOMAVIRUS REP, V12, P145
[7]   Performance of the Roche AMPLICOR® human papillomavirus (HPV) test in prediction of cervical intraepithelial neoplasia (CIN) in women with abnormal PAP smear [J].
Monsonego, J ;
Bohbot, JM ;
Pollini, G ;
Krawec, C ;
Vincent, C ;
Merignargues, I ;
Haroun, F ;
Sednaoui, P ;
Monfort, L ;
Dachez, R ;
Syrjänen, K .
GYNECOLOGIC ONCOLOGY, 2005, 99 (01) :160-168
[8]   Epidemiologic classification of human papillomavirus types associated with cervical cancer [J].
Muñoz, N ;
Bosch, FX ;
de Sanjosé, S ;
Herrero, R ;
Castellsagué, X ;
Shah, KV ;
Snijders, PJF ;
Meijer, CJLM .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (06) :518-527
[9]  
Schneede P, 2001, ACTA OBSTET GYN SCAN, V80, P750
[10]   Assessment of MagNA pure LC extraction system for detection of human papillomavirus (HPV) DNA in PreservCyt samples by the Roche AMPLICOR and LINEAR ARRAY HPV tests [J].
Stevens, Matthew P. ;
Rudland, Elice ;
Garland, Suzanne M. ;
TabriZil, Sepehr N. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (07) :2428-2433